Skip to content
Screener

Debt Repayments at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$35M-98.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$439.25M
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$15M-40.0%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$625K
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$5.24M

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.37B+11.7%
Enterprise value$21.83B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net cash used in investing activities(139)(130)
Cash Flows From Financing Activities
Issuance of long-term debt, net of discounts2,80250
Repayments of long-term debt(2,857)(168)
Payments of employee withholding taxes related to share-based awards(34)(16)
Payments of acquisition-related contingent consideration(8)(7)
Payments of financing costs(1)(5)
Other(2)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's debt repayments?
Bausch Health Companies (BHC) reported debt repayments of $2.86B in Q1 2026.
How has Bausch Health Companies's debt repayments changed year-over-year?
Bausch Health Companies's debt repayments increased by 1600.6% year-over-year, from $168M to $2.86B.
What is the long-term trend for Bausch Health Companies's debt repayments?
Over 4 years (2021 to 2025), Bausch Health Companies's debt repayments has grown at a 34.3% compound annual growth rate (CAGR), from $3.44B to $11.19B.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.

Ask your AI about Bausch Health Companies's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude